ApiJect

ApiJect's Platform and Technology

ApiJect offers a unique platform that integrates Blow-Fill-Seal (BFS) aseptic drug packaging technology with connectable components to create prefilled drug delivery systems. This innovative approach allows for efficient, sterile, and safe packaging of injectable drugs. By combining BFS technology with advanced connectable components, ApiJect provides a versatile solution for pharmaceutical companies looking to streamline their drug delivery processes. This platform is particularly beneficial for high-demand scenarios where rapid, reliable drug administration is crucial.

ApiJect's Licensing and Support Services

ApiJect provides comprehensive licensing and support services to pharmaceutical companies and Contract Development and Manufacturing Organizations (CDMOs). These services are designed to assist in the efficient fill-finish of injectable drug products, ensuring that pharmaceutical companies can deliver their products safely and effectively. Through its support services, ApiJect offers expertise in BFS technology, regulatory compliance, and quality assurance, which helps clients navigate the complexities of drug packaging and delivery. This holistic approach ensures that partners can optimize their production processes and meet industry standards.

ApiJect's Technology Development Center

Located in Orlando, Florida, ApiJect's Technology Development Center is dedicated to advancing BFS technology and supporting pharmaceutical companies with their drug delivery challenges. This state-of-the-art facility focuses on research and development to enhance the capabilities of BFS processes, particularly in accommodating the needs of temperature-sensitive biologics and vaccines. By investing in cutting-edge technology and innovation, the center plays a crucial role in helping pharmaceutical companies develop more efficient and effective drug delivery systems.

ApiJect's Temperature Management Methods

ApiJect employs proprietary temperature management methods within its Blow-Fill-Seal (BFS) processes, which are designed to enable the fill-finish of temperature-sensitive biologics and vaccines. This capability is particularly important for maintaining the stability and efficacy of sensitive drug formulations that require precise temperature control throughout the packaging process. By leveraging these advanced methods, ApiJect ensures that its drug delivery systems can safely handle a wide range of pharmaceutical products, including those with stringent temperature requirements.

ApiJect's Industry Recognition

ApiJect has been recognized for its innovative technology and contributions to the field of drug delivery. Notably, the company was named a Top 10 Drug Delivery Solutions Provider in both 2022 and 2023. This recognition highlights ApiJect's commitment to excellence and its role as a leader in the industry. Additionally, the company celebrated the 40th anniversary of the invention of the K-1 Auto-Disabled Syringe, a pivotal device credited with saving over 20 million lives by preventing syringe reuse. These accolades underscore ApiJect's impact on global health and its dedication to advancing drug delivery solutions.